| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 10/04/2001 | US20010026795 Antibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense system |
| 10/04/2001 | US20010026794 Two heterologous DNA encoding gene products; prolonged half-life |
| 10/04/2001 | EP1138773A2 Use of plasmids for the manufacture of a composition for vaccine treatment by human and animal |
| 10/04/2001 | EP1138692A1 Fragments of human chorionic gonadotropin (hcg) as immunoregulator |
| 10/04/2001 | EP1138680A1 Gem substituted sulfonyl hydroxamic acids as MMP inhibitors |
| 10/04/2001 | EP1138314A2 Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues |
| 10/04/2001 | EP1137806A1 Detection of rantes gene promoter polymorphisms |
| 10/04/2001 | EP1137792A1 A recombinant vector expressing multiple costimulatory molecules and uses thereof |
| 10/04/2001 | EP1137785A1 STREPTOCOCCAL C5a PEPTIDASE VACCINE |
| 10/04/2001 | EP1137769A1 T cells specific for target antigens and methods and vaccines based thereon |
| 10/04/2001 | EP1137759A2 Live attenuated venezuelan equine encephalitis vaccine |
| 10/04/2001 | EP1137758A2 Method and composition for preserving viruses |
| 10/04/2001 | EP1137664A2 Protein transduction system and methods of use thereof |
| 10/04/2001 | EP1137663A2 Purification of echinocandin cyclopeptide compounds |
| 10/04/2001 | EP1137658A1 METHODS OF MODULATING TUMOR NECROSIS FACTOR $g(a)-INDUCED EXPRESSION OF CELL ADHESION MOLECULES |
| 10/04/2001 | EP1137656A1 31 human secreted proteins |
| 10/04/2001 | EP1137655A1 Macrolide intermediates in the preparation of clarithromycin |
| 10/04/2001 | EP1137654A1 Carbamate and carbazate ketolide antibiotics |
| 10/04/2001 | EP1137647A1 Thiourea inhibitors of herpes viruses |
| 10/04/2001 | EP1137645A2 Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group |
| 10/04/2001 | EP1137640A1 Cyclic hydrazine derivatives as tnf-alpha inhibitors |
| 10/04/2001 | EP1137633A2 Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses |
| 10/04/2001 | EP1137632A1 Thiourea inhibitors of herpes viruses |
| 10/04/2001 | EP1137438A1 Formulation with an improved therapeutic range, containing nucleotide synthesis inhibitors |
| 10/04/2001 | EP1137423A2 Oral administration of lactobacillus for the treatment and prevention of urogenital infection |
| 10/04/2001 | EP1137411A1 Palladium-substituted bacteriochlorophyll derivatives and use thereof |
| 10/04/2001 | EP1137410A1 Novel 4-dedimethy laminotetra cycline derivatives |
| 10/04/2001 | EP1137408A1 Agent for lowering endothelin levels |
| 10/04/2001 | EP1137405A1 Active ingredient matrix in the form of a biologically resorbable porous non-woven made of collagen fibrils, method for the production and use thereof |
| 10/04/2001 | EP0912095B1 Phosphate composition and its utilization |
| 10/04/2001 | EP0835309B1 Vaccine for infectious agents, composition for treating and preventing hiv infections |
| 10/04/2001 | EP0835132B1 Recombinant temperature sensitive mutants of influenza virus |
| 10/04/2001 | EP0821665B1 Cyclobutane derivatives as inhibitors of squalene synthase and protein farnesyltransferase |
| 10/04/2001 | EP0802920B1 Antifungal fusacandins |
| 10/04/2001 | EP0802796B1 Chicken anaemia agent broiler vaccine |
| 10/04/2001 | EP0773222B1 Carbapenem derivative |
| 10/04/2001 | EP0772632B1 T cell stimulating protein of pestivirus |
| 10/04/2001 | EP0741712B1 Process for making hiv protease inhibitors |
| 10/04/2001 | EP0688314B1 Prodrug derivatives of enzyme inhibitors with hydroxyl groups, methods of preparing them and their use |
| 10/04/2001 | EP0682524B1 Pharmaceutical compositions containing bactericidal permeability increasing protein and a surfactant |
| 10/04/2001 | EP0674646B1 Lipid derivatives of phosphonoacids for liposomal incorporation and method of use |
| 10/04/2001 | EP0639979B1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF |
| 10/04/2001 | CA2429196A1 Characterization of grp94-ligand interactions and purification, screening, and therapeutic methods relating thereto |
| 10/04/2001 | CA2408806A1 Quinolonecarboxylic acid derivative |
| 10/04/2001 | CA2407036A1 A nucleic acid construct encoding a processing component derived from the n-terminal region of the hepatitis virus orf2, and an antigenic polypeptide |
| 10/04/2001 | CA2405502A1 Method of treating hepatitis delta viral infection |
| 10/04/2001 | CA2404662A1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors |
| 10/04/2001 | CA2404626A1 Novel piperazine derivatives |
| 10/04/2001 | CA2404532A1 Method of identifying inhibitors of tie-2 |
| 10/04/2001 | CA2404511A1 Tlr/cd14 binding inhibitor |
| 10/04/2001 | CA2404495A1 Human tap-like protein (transporter associated in antigen processing/presentation) |
| 10/04/2001 | CA2404478A1 Glycosaminoglycans derived from the k5 polysaccharide having high anticoagulant and antithrombotic activity and process for their preparation |
| 10/04/2001 | CA2404445A1 Tricyclic protein kinase inhibitors |
| 10/04/2001 | CA2404411A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 10/04/2001 | CA2404231A1 Methods of treating diseases with activated protein c |
| 10/04/2001 | CA2403993A1 Proteins for use as carriers in conjugate vaccines |
| 10/04/2001 | CA2403984A1 Recombinant iron uptake proteins |
| 10/04/2001 | CA2403857A1 Anti-angiogenic and anti-tumor properties of matin and other laminin domains |
| 10/04/2001 | CA2403800A1 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 10/04/2001 | CA2403787A1 Il-8 receptor antagonists |
| 10/04/2001 | CA2403764A1 Methods for immunostimulation using binding agents for the fc receptor of immunoglobulin a |
| 10/04/2001 | CA2402769A1 Ceramide derivatives and method of use |
| 10/04/2001 | CA2402735A1 Human transcription factors |
| 10/04/2001 | CA2402187A1 Intracorporeal medicaments comprising halogenated xanthene for photodynamic treatment of disease |
| 10/04/2001 | CA2401748A1 2-substituted 4-heteroaryl-pyrimidines and their use in the treatment of proliferative disorders |
| 10/04/2001 | CA2401638A1 Immuno-reactive peptide ctl epitopes of human cytomegalovirus |
| 10/04/2001 | CA2401242A1 Pharmaceutically active pyrrolidine derivatives |
| 10/04/2001 | CA2399287A1 Beta-glucans from filamentous fungi |
| 10/04/2001 | CA2374911A1 G-protein coupled receptors |
| 10/03/2001 | CN1316001A Polyketides and their synthesis |
| 10/03/2001 | CN1315965A Hepatitis C inhibitor peptides |
| 10/03/2001 | CN1315963A Benzodiazepines and benzothiazepines derivatives and HBSAG peptides binding to annexins, their compositions and use |
| 10/03/2001 | CN1315961A Glycopeptide derivatives and pharmaceutical compositions containing same |
| 10/03/2001 | CN1315956A Polyketides and their synthesis |
| 10/03/2001 | CN1315955A Novel carbapenem derivatives |
| 10/03/2001 | CN1315873A Prevention/remedies for multiple organ failure |
| 10/03/2001 | CN1315872A Multivalent huma-bovine retavirus vaccine |
| 10/03/2001 | CN1315871A Live attenuated i(salmonella) vaccines to control avian pathogens |
| 10/03/2001 | CN1315870A Derivatives of pneumococcal choline binding proteins for vaccines |
| 10/03/2001 | CN1315869A Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic LHRH peptides |
| 10/03/2001 | CN1315865A Stabilized pharmaceutical Composition in lyophilized form |
| 10/03/2001 | CN1315863A Use of rosmarinic acid and derivatives thereof as immunosuppressant or inhibitor of SHz-mediated process |
| 10/03/2001 | CN1315206A Interferon suppository and its preparing process |
| 10/03/2001 | CN1315191A Oral liquid for clearing heat and detoxicating and its preparing process |
| 10/03/2001 | CN1315189A Tea for treating cold and its preparing process |
| 10/03/2001 | CN1315187A Compound and liquid for relieving inflammation and pain |
| 10/03/2001 | CN1315176A Application of bilirubin bitaurine sodium and its bilirubin derivative in preparing anti-HIV medicine |
| 10/03/2001 | CN1072222C Phenyloxazolidinones having C-C bond to 4-8 membered heterocyclic rings |
| 10/03/2001 | CN1071992C Ionene polymers as microbicides |
| 10/02/2001 | US6297281 Association of no syntase inhibitors with trappers of oxygen reactive forms |
| 10/02/2001 | US6297278 Low cytotoxicity synergistic mixture of a betaine, an amine oxide and an acid in an amount to provide the composition with a ph of 4-8 |
| 10/02/2001 | US6297277 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 10/02/2001 | US6297266 Inhibit the binding of adhesive proteins to the surface of different types of cell and accordingly influence cell-cell and cell-matrix interactions. |
| 10/02/2001 | US6297265 Benzoisothiazole-substituted compounds useful as IL-8 receptor antagonists |
| 10/02/2001 | US6297260 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 10/02/2001 | US6297253 Inactivating a nuclear localization signal of a protein comprising contacting the protein with an aryl carbonyl compound that forms stable reversible covalent interactions with neighboring basic amino acid residues |
| 10/02/2001 | US6297242 Active against methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococci and penicillin- and cephalosporin-resistant streptococcus pneumoniae. |
| 10/02/2001 | US6297239 Inhibitors of prenyl-protein transferase |
| 10/02/2001 | US6297238 3-aryl pyrazoles with 4,5(3,4)-bicyclic ring fusion which are inhibitors of protein kinases particularly tyrosine kinases and serine/threonine kinases |
| 10/02/2001 | US6297231 Stabilized carbapenem antibiotic compositions and method of making |